UK markets close in 6 hours 13 minutes

Schrödinger, Inc. (SDGR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.38-0.06 (-0.25%)
At close: 04:00PM EDT
24.17 -0.21 (-0.86%)
After hours: 07:37PM EDT

Schrödinger, Inc.

1540 Broadway
24th Floor
New York, NY 10036
United States
212 295 5800
https://www.schrodinger.com

Sector(s)Healthcare
IndustryHealth Information Services
Full-time employees867

Key executives

NameTitlePayExercisedYear born
Dr. Ramy Farid Ph.D.CEO, President & Director1.06M1.14M1965
Dr. Richard A. Friesner Ph.D.Co-Founder, Scientific Advisory Chairman and Director465kN/A1953
Dr. Geoffrey Craig Porges MBBSExecutive VP & CFO888.15kN/AN/A
Dr. Robert Lorne Abel Ph.D.Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D569.45kN/A1982
Dr. Karen Akinsanya Ph.D.President of Research & Development Therapeutics797.74kN/A1968
Dr. Margaret Han Dugan M.D.Chief Medical Officer707.46kN/A1957
Prof. William Goddard IIICo-Founder & Scientific AdvisorN/AN/AN/A
Mr. Kenneth Patrick LortonExecutive VP, CTO & COO of Software510.09k395.9k1984
Mr. Shane BraunerExecutive VP & Chief Information OfficerN/AN/A1978
Ms. Jaren Irene MaddenSenior Vice President of Investor Relations & Corporate CommunicationsN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Corporate governance

Schrödinger, Inc.’s ISS governance QualityScore as of 29 April 2024 is 6. The pillar scores are Audit: 4; Board: 6; Shareholder rights: 3; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.